SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

[1]  S. Munro,et al.  Molecular characterization of a peripheral receptor for cannabinoids , 1993, Nature.

[2]  P. Casellas,et al.  Cannabinoid-receptor expression in human leukocytes. , 1993, European journal of biochemistry.

[3]  D. Gibson,et al.  Isolation and structure of a brain constituent that binds to the cannabinoid receptor. , 1992, Science.

[4]  L. Gold,et al.  Aminoalkylindole analogs: cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol. , 1992, The Journal of pharmacology and experimental therapeutics.

[5]  N. Kaminski,et al.  Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation. , 1992, Molecular pharmacology.

[6]  L. Matsuda,et al.  Cannabinoid agonists stimulate both receptor- and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones. , 1992, Molecular pharmacology.

[7]  T. Croci,et al.  Phenylethanolaminotetralines compete with [3H]dihydroalprenolol binding to rat colon membranes without evidencing atypical beta-adrenergic sites. , 1992, Biochemical pharmacology.

[8]  R. Mechoulam,et al.  A novel probe for the cannabinoid receptor. , 1992, Journal of medicinal chemistry.

[9]  M. Eissenstat,et al.  Conformationally restrained analogues of pravadoline: nanomolar potent, enantioselective, (aminoalkyl)indole agonists of the cannabinoid receptor. , 1992, Journal of medicinal chemistry.

[10]  G Vassart,et al.  Molecular cloning of a human cannabinoid receptor which is also expressed in testis. , 1991, The Biochemical journal.

[11]  S. Childers,et al.  Aminoalkylindoles: actions on specific G-protein-linked receptors. , 1991, The Journal of pharmacology and experimental therapeutics.

[12]  M. Kaghad,et al.  Human interleukin 1 beta fused to the human growth hormone signal peptide is N-glycosylated and secreted by Chinese hamster ovary cells. , 1991, Gene.

[13]  S. Ward,et al.  Pravadoline: profile in isolated tissue preparations. , 1990, The Journal of pharmacology and experimental therapeutics.

[14]  T. Bonner,et al.  Structure of a cannabinoid receptor and functional expression of the cloned cDNA , 1990, Nature.

[15]  A. Howlett,et al.  Cannabinoid Receptors and Modulation of Cyclic AMP Accumulation in the Rat Brain , 1990, Journal of neurochemistry.

[16]  A. Howlett,et al.  Determination and characterization of a cannabinoid receptor in rat brain. , 1988, Molecular pharmacology.

[17]  A. Howlett,et al.  Nonclassical cannabinoid analgetics inhibit adenylate cyclase: development of a cannabinoid receptor model. , 1988, Molecular pharmacology.

[18]  P. Ferrara,et al.  Characterization of recombinant glycosylated human interleukin 2 produced by a recombinant plasmid transformed CHO cell line , 1987, FEBS letters.

[19]  L E Hollister,et al.  Health aspects of cannabis. , 1986, Pharmacological reviews.

[20]  T. Spector.  Refinement of the Coomassie blue method of protein quantitation: A simple and linear spectrophotometric assay for ≤0.5 to 50 μg of protein , 1978 .

[21]  M. Lazdunski,et al.  Effects of neurotoxins (veratridine, sea anemone toxin, tetrodotoxin) on transmitter accumulation and release by nerve terminals in vitro. , 1977, Biochemistry.

[22]  M. Cohn,et al.  ‘Barrel rotation’ induced by somatostatin in the non-lesioned rat , 1975, Brain Research.

[23]  R. Pertwee.  The ring test: a quantitative method for assessing the ‘cataleptic’ effect of cannabis in mice , 1972, British journal of pharmacology.

[24]  Fred E. D'Amour,et al.  A METHOD FOR DETERMINING LOSS OF PAIN SENSATION , 1941 .